Don't Assume Your ANDA Will Be Designated, US FDA Tells Aspiring Competitive Generic Therapy Sponsors

 
• By Derrick Gingery
  
FDA entrance sign 2016
The FDA clarified some aspects of the competitive generic therapies program in its final guidance. • Source: File photo

More from Generics

More from Biosimilars & Generics